These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

545 related articles for article (PubMed ID: 14674008)

  • 1. Reduction in the evolution of murine type II collagen-induced arthritis by treatment with rosiglitazone, a ligand of the peroxisome proliferator-activated receptor gamma.
    Cuzzocrea S; Mazzon E; Dugo L; Patel NS; Serraino I; Di Paola R; Genovese T; Britti D; De Maio M; Caputi AP; Thiemermann C
    Arthritis Rheum; 2003 Dec; 48(12):3544-56. PubMed ID: 14674008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CGS 21680, an agonist of the adenosine (A2A) receptor, reduces progression of murine type II collagen-induced arthritis.
    Mazzon E; Esposito E; Impellizzeri D; DI Paola R; Melani A; Bramanti P; Pedata F; Cuzzocrea S
    J Rheumatol; 2011 Oct; 38(10):2119-29. PubMed ID: 21765105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythropoietin reduces the degree of arthritis caused by type II collagen in the mouse.
    Cuzzocrea S; Mazzon E; di Paola R; Genovese T; Patel NS; Britti D; de Majo M; Caputi AP; Thiemermann C
    Arthritis Rheum; 2005 Mar; 52(3):940-50. PubMed ID: 15751086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absence of endogeneous interleukin-10 enhances the evolution of murine type-II collagen-induced arthritis.
    Cuzzocrea S; Mazzon E; Dugo L; Serraino I; Britti D; De Maio M; Caputi AP
    Eur Cytokine Netw; 2001; 12(4):568-80. PubMed ID: 11781183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oleuropein aglycone, an olive oil compound, ameliorates development of arthritis caused by injection of collagen type II in mice.
    Impellizzeri D; Esposito E; Mazzon E; Paterniti I; Di Paola R; Morittu VM; Procopio A; Britti D; Cuzzocrea S
    J Pharmacol Exp Ther; 2011 Dec; 339(3):859-69. PubMed ID: 21880869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cloricromene, a coumarine derivative, protects against collagen-induced arthritis in Lewis rats.
    Cuzzocrea S; Mazzon E; Bevilaqua C; Costantino G; Britti D; Mazzullo G; De Sarro A; Caputi AP
    Br J Pharmacol; 2000 Dec; 131(7):1399-407. PubMed ID: 11090113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type II collagen-induced arthritis in the diabetic-resistant biobreeding rat: inflammatory and histopathological features of joint pathology and effects of antiinflammatory and antirheumatic drugs on this chronic arthritic process.
    Smith RJ; Sly LM
    J Pharmacol Exp Ther; 1996 Jun; 277(3):1801-13. PubMed ID: 8667252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beneficial effects of tempol, a membrane-permeable radical scavenger, in a rodent model of collagen-induced arthritis.
    Cuzzocrea S; McDonald MC; Mota-Filipe H; Mazzon E; Costantino G; Britti D; Mazzullo G; Caputi AP; Thiemermann C
    Arthritis Rheum; 2000 Feb; 43(2):320-8. PubMed ID: 10693871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ethyl pyruvate therapy attenuates experimental severe arthritis caused by type II collagen (CII) in the mouse (CIA).
    Di Paola R; Mazzon E; Galuppo M; Esposito E; Bramanti P; Fink MP; Cuzzocrea S
    Int J Immunopathol Pharmacol; 2010; 23(4):1087-98. PubMed ID: 21244758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amelioration of joint disease in a rat model of collagen-induced arthritis by M40403, a superoxide dismutase mimetic.
    Salvemini D; Mazzon E; Dugo L; Serraino I; De Sarro A; Caputi AP; Cuzzocrea S
    Arthritis Rheum; 2001 Dec; 44(12):2909-21. PubMed ID: 11762952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycogen synthase kinase-3beta inhibition attenuates the degree of arthritis caused by type II collagen in the mouse.
    Cuzzocrea S; Mazzon E; Di Paola R; Muià C; Crisafulli C; Dugo L; Collin M; Britti D; Caputi AP; Thiemermann C
    Clin Immunol; 2006 Jul; 120(1):57-67. PubMed ID: 16631408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of combination M40403 and dexamethasone therapy on joint disease in a rat model of collagen-induced arthritis.
    Cuzzocrea S; Mazzon E; Paola RD; Genovese T; Muià C; Caputi AP; Salvemini D
    Arthritis Rheum; 2005 Jun; 52(6):1929-40. PubMed ID: 15934059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. THR0921, a novel peroxisome proliferator-activated receptor gamma agonist, reduces the severity of collagen-induced arthritis.
    Tomita T; Kakiuchi Y; Tsao PS
    Arthritis Res Ther; 2006; 8(1):R7. PubMed ID: 16356194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2, ligands of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma), reduce ischaemia/reperfusion injury of the gut.
    Cuzzocrea S; Pisano B; Dugo L; Ianaro A; Patel NS; Di Paola R; Genovese T; Chatterjee PK; Di Rosa M; Caputi AP; Thiemermann C
    Br J Pharmacol; 2003 Sep; 140(2):366-76. PubMed ID: 12970094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
    Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
    Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-gamma, reduces the development of nonseptic shock induced by zymosan in mice.
    Cuzzocrea S; Pisano B; Dugo L; Ianaro A; Patel NS; Di Paola R; Genovese T; Chatterjee PK; Fulia F; Cuzzocrea E; Di Rosa M; Caputi AP; Thiemermann C
    Crit Care Med; 2004 Feb; 32(2):457-66. PubMed ID: 14758164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absence of endogenous interleukin-10 enhances the evolution of acute lung injury.
    Cuzzocrea S; Mazzon E; Dugo L; Serraino I; Di Paola R; Genovese T; De Sarro A; Caputi AP
    Eur Cytokine Netw; 2002; 13(3):285-97. PubMed ID: 12231472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion.
    Lubberts E; Koenders MI; Oppers-Walgreen B; van den Bersselaar L; Coenen-de Roo CJ; Joosten LA; van den Berg WB
    Arthritis Rheum; 2004 Feb; 50(2):650-9. PubMed ID: 14872510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. (5R)-5-hydroxytriptolide attenuated collagen-induced arthritis in DBA/1 mice via suppressing interferon-gamma production and its related signaling.
    Zhou R; Tang W; Ren YX; He PL; Zhang F; Shi LP; Fu YF; Li YC; Ono S; Fujiwara H; Yang YF; Zuo JP
    J Pharmacol Exp Ther; 2006 Jul; 318(1):35-44. PubMed ID: 16574782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beneficial effects of GW274150, a novel, potent and selective inhibitor of iNOS activity, in a rodent model of collagen-induced arthritis.
    Cuzzocrea S; Chatterjee PK; Mazzon E; McDonald MC; Dugo L; Di Paola R; Serraino I; Britti D; Caputi AP; Thiemermann C
    Eur J Pharmacol; 2002 Oct; 453(1):119-29. PubMed ID: 12393067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.